Topical Eutectic Mixture for Premature Ejaculation - MedpharmaAlternative Names: TEMPE
Latest Information Update: 24 Aug 2004
At a glance
- Originator Medpharma
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 28 Dec 2003 Discontinued - Phase-II for Premature ejaculation in United Kingdom (Topical)
- 28 Jun 2003 Phase-II clinical trials in Premature ejaculation in United Kingdom (Topical)